NCT06383572
- Conditions
- Lymphodepleting Chemotherapy, Myeloid Malignancies
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying Lymphodepleting Chemotherapy. Study availability and eligibility vary by location and protocol.
NCT06383572